Literature DB >> 30646187

Fetal Valproate Exposure and Attention-Deficit/Hyperactivity Disorder.

Kimford J Meador1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 30646187      PMCID： PMC7751890          DOI： 10.1001/jamanetworkopen.2018.6603

Source DB:  PubMed          Journal:  JAMA Netw Open        ISSN： 2574-3805


× No keyword cloud information.
  5 in total

Review 1.  Developmental effects of antiepileptic drugs and the need for improved regulations.

Authors:  Kimford J Meador; David W Loring
Journal:  Neurology       Date:  2015-10-30       Impact factor: 9.910

2.  Comparative risk of major congenital malformations with eight different antiepileptic drugs: a prospective cohort study of the EURAP registry.

Authors:  Torbjörn Tomson; Dina Battino; Erminio Bonizzoni; John Craig; Dick Lindhout; Emilio Perucca; Anne Sabers; Sanjeev V Thomas; Frank Vajda
Journal:  Lancet Neurol       Date:  2018-04-18       Impact factor: 44.182

3.  Comparative safety of antiepileptic drugs during pregnancy.

Authors:  S Hernández-Díaz; C R Smith; A Shen; R Mittendorf; W A Hauser; M Yerby; L B Holmes
Journal:  Neurology       Date:  2012-05-02       Impact factor: 9.910

4.  Prenatal valproate exposure and risk of autism spectrum disorders and childhood autism.

Authors:  Jakob Christensen; Therese Koops Grønborg; Merete Juul Sørensen; Diana Schendel; Erik Thorlund Parner; Lars Henning Pedersen; Mogens Vestergaard
Journal:  JAMA       Date:  2013-04-24       Impact factor: 56.272

5.  Fetal antiepileptic drug exposure and cognitive outcomes at age 6 years (NEAD study): a prospective observational study.

Authors:  Kimford J Meador; Gus A Baker; Nancy Browning; Morris J Cohen; Rebecca L Bromley; Jill Clayton-Smith; Laura A Kalayjian; Andres Kanner; Joyce D Liporace; Page B Pennell; Michael Privitera; David W Loring
Journal:  Lancet Neurol       Date:  2013-01-23       Impact factor: 44.182
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.